Literature DB >> 7900524

Couples' willingness to pay for IVF/ET.

M Granberg1, M Wikland, L Nilsson, L Hamberger.   

Abstract

BACKGROUND: Many politicians and decision-makers in health care consider assisted reproduction an expensive and exclusive treatment despite the results of in vitro fertilization/embryo transfer (IVF/ET) treatments having improved considerably during the last few years. With the improved results the costs in relation to successful outcome are decreasing. AIM AND METHODS: The aim of this study was to evaluate the cost-benefit of IVF/ET treatments in a group of infertile couples. The benefit was measured as willingness to pay (WTP) for IVF/ET treatment and was related to the cost of IVF/ET: For the calculation of costs, data from one private and one public IVF clinic in Sweden during the period from January 1992 to March 1993 were used. RESULTS AND
CONCLUSIONS: The cost analysis showed a direct cost for IVF/ET of 3,170 pounds per started treatment and 9,410 pounds per delivery. Including the indirect cost, the total cost was 3,880 pounds per started IVF/ET treatment and 11,490 pounds per delivery. The survey of the WTP showed that the infertile couples gave high economic priority to infertility treatment. A majority of the couples were willing to pay more for a child than the calculated direct cost.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1995        PMID: 7900524     DOI: 10.3109/00016349509008938

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Conjoint analysis of a new Chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced Colorectal Cancer.

Authors:  Mike Aristides; Jack Chen; Mark Schulz; Eve Williamson; Stephen Clarke; Kaye Grant
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Willingness to pay for ovulation induction treatment in case of WHO II anovulation: a study using the contingent valuation method.

Authors:  Thomas G Poder; Jie He; Catherine Simard; Jean-Charles Pasquier
Journal:  Patient Prefer Adherence       Date:  2014-09-26       Impact factor: 2.711

3.  Projecting the potential impact of the Cap-Score™ on clinical pregnancy, live births, and medical costs in couples with unexplained infertility.

Authors:  Joseph B Babigumira; Fady I Sharara; Louis P Garrison
Journal:  J Assist Reprod Genet       Date:  2017-09-23       Impact factor: 3.412

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.